ACADIAN ASSET MANAGEMENT LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 118 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15
-25.0%
679
+26.0%
0.00%
Q4 2022$20
-100.0%
539
-60.4%
0.00%
Q3 2022$68,000
+9.7%
1,361
-7.0%
0.00%
Q2 2021$62,000
-24.4%
1,464
-39.9%
0.00%
Q2 2018$82,000
-81.4%
2,437
-85.0%
0.00%
-100.0%
Q1 2018$440,000
+86.4%
16,232
+38.0%
0.00%
+100.0%
Q3 2017$236,000
-14.8%
11,762
-53.7%
0.00%0.0%
Q4 2016$277,00025,4210.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders